SIVORI, SIMONA
 Distribuzione geografica
Continente #
EU - Europa 14.850
AS - Asia 605
NA - Nord America 80
SA - Sud America 76
AF - Africa 9
Totale 15.620
Nazione #
IT - Italia 14.833
SG - Singapore 253
CN - Cina 182
VN - Vietnam 128
US - Stati Uniti d'America 65
BR - Brasile 52
HK - Hong Kong 18
MX - Messico 15
AR - Argentina 13
IQ - Iraq 6
EC - Ecuador 5
ID - Indonesia 5
RU - Federazione Russa 5
BD - Bangladesh 4
ES - Italia 3
NL - Olanda 3
ZA - Sudafrica 3
OM - Oman 2
PK - Pakistan 2
TN - Tunisia 2
BF - Burkina Faso 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CH - Svizzera 1
CL - Cile 1
CO - Colombia 1
DJ - Gibuti 1
EG - Egitto 1
GB - Regno Unito 1
GF - Guiana Francese 1
GY - Guiana 1
IN - India 1
IR - Iran 1
JO - Giordania 1
KE - Kenya 1
MD - Moldavia 1
NO - Norvegia 1
PE - Perù 1
UA - Ucraina 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 15.620
Città #
Genova 8.950
Genoa 3.569
Rapallo 1.172
Vado Ligure 1.074
Singapore 106
Beijing 54
Ho Chi Minh City 50
Bordighera 46
Ashburn 40
Hanoi 35
Hong Kong 17
Mexico City 14
Haiphong 9
Tianjin 9
Los Angeles 7
Milan 7
Da Nang 6
Quảng Ngãi 4
Brasília 3
Chieti 3
New York 3
São Paulo 3
Albuzzano 2
Amsterdam 2
Baghdad 2
Barcelona 2
Brooklyn 2
Buenos Aires 2
Formosa 2
Guayaquil 2
Ha Long 2
Itanhaém 2
Jakarta 2
Nha Trang 2
Rondonópolis 2
Santa Clara 2
Seeb 2
Thái Bình 2
Venice 2
Amman 1
Ananindeua 1
Arequipa 1
Balsas 1
Bandar Seri Begawan 1
Barra do Piraí 1
Biên Hòa 1
Boituva 1
Boksburg 1
Bologna 1
Bom Jardim 1
Boqueirão do Leão 1
Boston 1
Brest 1
Bình Dương 1
Cairo 1
Caldas Novas 1
Camaçari 1
Campo Largo 1
Caracas 1
Cariacica 1
Cayenne 1
Chisinau 1
Chordeleg 1
Colombo 1
Colônia do Piauí 1
Coronel Brandsen 1
Corrientes 1
Cuenca 1
Cáceres 1
Dallas 1
Del Viso 1
Denver 1
Dhaka 1
Duhok 1
Duque de Caxias 1
Elista 1
Esmeraldas 1
Estación Colina 1
Esteio 1
Georgetown 1
Goiânia 1
Goya 1
Guilin 1
Hưng Yên 1
Ibach 1
Irajuba 1
Itamaraju 1
Ituzaingó 1
Jessore 1
Johannesburg 1
Karachi 1
Karbala 1
Luján de Cuyo 1
Luís Correia 1
Lyubertsy 1
Macarani 1
Makhachkala 1
Malvinas Argentinas 1
Maringá 1
Medellín 1
Totale 15.276
Nome #
Activating KIRs and NKG2C in viral infections: Toward NK cell memory? 216
New miRNA signature heralds human NK cell subsets at different maturation steps: Involvement of miR-146a-5p in the regulation of KIR expression 197
2B4 functions as a co-receptor in human NK cell activation 190
Different features of tumor-associated NK cells in patients with low-grade or high-grade peritoneal carcinomatosis 186
Features of Memory-Like and PD-1+ Human NK Cell Subsets 182
A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation. 182
CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells. 179
Bridging innate NK cell Functions with Adaptive Immunity. 178
Natural Killer (NK)/melanoma cell interaction induces NK-mediated release of chemotactic High Mobility Group Box-1 (HMGB1) capable of amplifying NK cell recruitment 177
NK/DC crosstalk in anti-viral response. 176
Uptake of CCR7 by KIR2DS4⁺ NK cells is induced upon recognition of certain HLA-C alleles 174
Late development of FcεRγneg adaptive natural killer cells upon human cytomegalovirus reactivation in umbilical cord blood transplantation recipients 173
Dysregulation of regulatory CD56bright NK cells/T cells interactions in multiple sclerosis 173
Function and specificity of human natural killer cell receptors. 170
KIR3DS1-Mediated Recognition of HLA-*B51: Modulation of KIR3DS1 Responsiveness by Self HLA-B Allotypes and Effect on NK Cell Licensing 167
A novel mechanism of antitumor response involving the expansion of CD3+/CD56+ large granular lymphocytes triggered by a tumor-expressed activating ligand. 165
CD45-mediated regulation of LFA1 function in human natural killer cells. Anti-CD45 monoclonal antibodies inhibit the calcium mobilization induced via LFA1 molecules. 164
NK cells and their receptors during viral infections. 164
Efficacy of third-party chimeric antigen receptor modified peripheral blood natural killer cells for adoptive cell therapy of B-cell precursor acute lymphoblastic leukemia 163
An Historical Overview: The Discovery of How NK Cells Can Kill Enemies, Recruit Defense Troops, and More 162
Markers and function of human NK cells in normal and pathological conditions 161
Human NK receptors: from the molecules to the therapy of high risk leukemias. 157
Stimulatory receptors in NK and T cells. 155
Comparison of different CpG oligodeoxynucleotide classes for their capability to stimulate human NK cells 155
Harnessing NK Cells for Cancer Treatment 155
Role of amino acid position 70 in the binding affinity of p50.1 and p58.1 receptors for HLA-Cw4 molecules. 155
Triggering receptors involved in natural killer cell-mediated cytotoxicity against choriocarcinoma cell lines 151
CD56 is a pathogen recognition receptor on human natural killer cells 151
Human NK cell response to pathogens 149
CD4(+) cutaneous T-cell lymphoma cells express the p140-killer cell immunoglobulin-like receptor. 148
CD59 is physically and functionally associated with natural cytotoxicity receptors and activates human NK cell-mediated cytotoxicity 146
Report from the Eleventh Killer Immunoglobulin-like Receptor (KIR) Workshop: novel insights on KIR polymorphism, ligand recognition, expression and function 146
NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells 142
Natural killer lymphocytes: "null cells" no more. 142
Extending killer Ig-like receptor function: from HLA class I recognition to sensors of microbial products 141
Early expression of triggering receptors and regulatory role of 2B4 in human natural killer cell precursors undergoing in vitro differentiation. 139
PD/1-PD-Ls Checkpoint: Insight on the Potential Role of NK Cells 139
Involvement of natural cytotoxicity receptors in human natural killer cell-mediated lysis of neuroblastoma and glioblastoma cell lines 137
Molecular and functional characterization of IRp60, a member of the immunoglobulin superfamily that functions as an inhibitory receptor in human NK cells. 137
Human NK Cells and Herpesviruses: Mechanisms of Recognition, Response and Adaptation 136
Pathogen-induced private conversations between natural killer and dendritic cells 135
Expression and function of the natural cytotoxicity receptor NKp46 on circulating malignant CD4+ T lymphocytes of Sézary syndrome patients 135
TLR/NCR/KIR: Which One to Use and When? 133
Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity. 133
Early liaisons between cells of the innate immune system in inflamed peripheral tissues 132
Unraveling the regulatory role of NK cells on T-cell effector functions: Implications for CNS autoimmunity 131
Natural killer cell-triggering receptors in patients with acute leukaemia. 131
Natural Killer cells expressing the KIR2DS1 activating receptor efficiently kill T cell blasts and dendritic cells: implications in haploidentical HSCT. 131
CD94 functions as a natural killer cell inhibitory receptor for different HLA class I alleles: identification of the inhibitory form of CD94 by the use of novel monoclonal antibodies. 129
Identification of a new surface molecule involved in the mechanism of cell to cell adhesion between human NK and tumor target cells. 128
Natural killer cells expressing the KIR2DS1 activating receptor efficiently kill T cell blasts and dendritic cells: implications in haploidentical HSCT 127
Human natural killer cell receptors for HLA-class I molecules. Evidence that the Kp43 (CD94) molecule functions as receptor for HLA-B alleles. 126
Downregulation of HLA Class I Renders Inflammatory Neutrophils More Susceptible to NK Cell-Induced Apoptosis 126
IFN-alpha-mediated increase in cytolytic activity of maturing NK cell upon exposure to HSV-infected myelomonocytes. 125
IL-21 induces both rapid maturation of human CD34+ cell precursors towards NK cells and acquisition of surface killer Ig-like receptors 125
A novel KIR-associated function: evidence that CpG DNA uptake and shuttling to early endosomes is mediated by KIR3DL2 125
Heterogeneity of TLR3 mRNA transcripts and responsiveness to poly (I:C) in human NK cells derived from different donors 125
p40, a novel surface molecule involved in the regulation of the non-major histocompatibility complex-restricted cytolytic activity in humans. 122
Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. 122
Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia 121
NK cells: innate immunity against hematological malignancies? 120
CD19 Redirected CAR NK Cells Are Equally Effective but Less Toxic Than CAR T Cells 120
Role of alloreactive KIR2DS1+ NK cells in haploidentical hematopoietic stem cell transplantation. 119
Identification and molecular characterization of a natural mutant of the p50.2/KIR2DS2 activating NK receptor that fails to mediate NK cell triggering. 117
NK Cell-Based Immunotherapy for Hematological Malignancies 117
Expression and Function of the Natural Cytotoxicity Receptor NKp46 on Circulating Malignant CD4(+) T Lymphocytes of Sézary Syndrome Patients. 116
Cutaneous T Cell Lymphoma Cells Express a Novel Allelic Form of the p140/Killer Cell Immunoglobulin-Like Receptor 116
Analysis of KIR3DP1 Polymorphism Provides Relevant Information on Centromeric KIR Gene Content 116
Identification and molecular cloning of p75/AIRM1, a novel member of the sialoadhesin family that functions as an inhibitory receptor in human natural killer cells. 115
Coexpression of two functionally independent p58 inhibitory receptors in human natural killer cell clones results in the inability to kill all normal allogeneic target cells. 115
Human natural killer cell receptors and co-receptors. 114
NK Receptors: Tools for a Polyvalent Cell Family 114
New miRNA signature heralds human NK cell subsets at different maturation steps: involvement of miR- 146a-5p in the regulation of KIR expression 114
NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. 113
Extrathymic differentiation of T lymphocytes and natural killer cells from human embryonic liver precursors. 113
ANALYSIS OF THE INTERACTION OF MATURING NK CELLS WITHREPLICATING VIRUSES: STRONG UPREGULATION OF NCREXPRESSION AND OF CYTOTOXICITY BY HSV-1, NOT BY HIV-1 113
De novo expression of CCR7 and acquisition of migratory properties by human KIR2DS1+ NK cells interacting with allogeneic HLA-C2+ monocyte-derived DC or T cell blasts. 111
NK Cell-Based Immunotherapy in Colorectal Cancer 110
General role of HLA class I molecules in the protection of target cells from lysis by natural killer cells: evidence that the free heavy chains of class I molecules are not sufficient to mediate the protective effect. 110
Dysregulation of regulatory CD56 (bright) NK cells/T cells interactions in multiple sclerosis 110
Strengthening the AntiTumor NK Cell Function for the Treatment of Ovarian Cancer 110
p46, a novel natural killer cell-specific surface molecule that mediates cell activation. 109
Role of the main non HLA-specific activating NK receptors in pancreatic, colorectal and gastric tumors surveillance 109
miRNAs in NK Cell-Based Immune Responses and Cancer Immunotherapy 108
KIR2DS1-dependent acquisition of CCR7 and migratory properties by human NK cells interacting with allogeneic HLA-C2+ DC or T cell blasts. 107
Heterogeneity of TLR3 mRNA transcripts and responsiveness to poly (I:C) in human NK cells derived from different donors 107
NKp44-NKp44 Ligand Interactions in the Regulation of Natural Killer Cells and Other Innate Lymphoid Cells in Humans 107
Physical and functional independency of p70 and p58 natural killer (NK) cell receptors for HLA class I: their role in the definition of different groups of alloreactive NK cell clones. 105
KIR2DS1-dependent acquisition of CCR7 and migratory properties by human NK cells interacting with allogeneic HLA-C2+ DC or T cell blasts 104
In Celiac Disease, a Subset of Autoantibodies against Transglutaminase Binds Toll-like Receptor 4 and Induces Activation of Monocytes. 104
HLA-G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex. 104
KIR2DS1-dependent acquisition of CCR7 and migratory properties by human NK cells interacting with allogeneic HLA-C2+ DC or T cell blasts 103
Human NK cells: surface receptors, inhibitory checkpoints, and translational applications 103
KIR2DS1-dependent acquisition of CCR7 and migratory properties by human NK cells interacting with allogeneic HLA-C2+ DC or T cell blasts 101
NTB-A, a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease. 101
The activating form of CD94 receptor complex: CD94 covalently associates with the Kp39 protein that represents the product of the NKG2-C gene. 100
Elementi di istologia e cenni di embriologia 96
The human natural killer cell receptor for major histocompatibility complex class I molecules. Surface modulation of p58 molecules and their linkage to CD3 zeta chain, Fc epsilon RI gamma chain and the p56lck kinase. 95
Inhibitory and activatory receptors for HLA class I molecules in human natural killer cells. 94
Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells. 94
Totale 13.396
Categoria #
all - tutte 51.166
article - articoli 44.681
book - libri 934
conference - conferenze 4.566
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 985
Totale 102.332


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021725 0 0 0 0 0 164 75 68 107 135 85 91
2021/20221.471 57 107 130 149 53 91 80 331 72 152 67 182
2022/20231.445 156 109 17 148 224 247 2 122 257 10 129 24
2023/2024773 48 94 17 93 71 76 36 78 56 46 47 111
2024/20252.547 62 180 136 150 357 253 235 373 93 131 251 326
2025/20261.928 524 121 284 304 598 97 0 0 0 0 0 0
Totale 15.897